Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 9;11(2):e0148896.
doi: 10.1371/journal.pone.0148896. eCollection 2016.

Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses

Affiliations

Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses

Elin Manell et al. PLoS One. .

Abstract

Diabetes mellitus is increasing worldwide and reliable animal models are important for progression of the research field. The pig is a commonly used large animal model in diabetes research and the present study aimed to refine a model for oral glucose tolerance test (OGTT) in young growing pigs, as well as describing intravenous glucose tolerance test (IVGTT) in the same age group. The refined porcine OGTT will reflect that used in children and adolescents. Eighteen pigs were obtained one week after weaning and trained for two weeks to bottle-feed glucose solution, mimicking the human OGTT. The pigs subsequently underwent OGTT (1.75 g/kg BW) and IVGTT (0.5 g/kg BW). Blood samples were collected from indwelling vein catheters for measurements of glucose and the diabetes related hormones insulin, glucagon and active glucagon-like peptide-1. The study confirmed that pigs can be trained to bottle-feed glucose dissolved in water and thereby undergo an OGTT more similar to the human standard OGTT than previously described methods in pigs. With the refined method for OGTT, oral intake only consists of glucose and water, which is an advantage over previously described methods in pigs where glucose is given together with feed which will affect glucose absorption. Patterns of hormonal secretion in response to oral and intravenous glucose were similar to those in humans; however, the pigs were more glucose tolerant with lower insulin levels than humans. In translational medicine, this refined OGTT and IVGTT methods provide important tools in diabetes research when pigs are used as models for children and adolescents in diabetes research.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Bottle-feeding training of an eight week old pig.
Fig 2
Fig 2. Scheme of the pigs included in IVGTT and OGTT from litter 1 (L1; Yorkshire x Swedish Landrace) and litter 2 (L2; Yorkshire x Swedish Landrace x Hampshire).
Fig 3
Fig 3. Blood glucose concentrations and plasma levels of insulin, glucagon and baseline subtracted (change from fasting levels) active GLP-1 during OGTT (1.75 g/kg BW, n = 9 for blood glucose and plasma insulin, n = 5 for plasma glucagon and active GLP-1) in growing pigs.
* indicate a significant increase and † a significant decrease compared to fasting levels (*, † = p<0.05; **, †† = p<0.01; ***, ††† = p<0.001).
Fig 4
Fig 4. Blood glucose concentrations and plasma levels of insulin, glucagon and baseline subtracted (change from fasting levels) active GLP-1 during IVGTT (0.5 g/kg BW, n = 18) in growing pigs.
* indicate a significant increase and † a significant decrease compared to fasting levels (*, † = p<0.05; **, †† = p<0.01; ***, ††† = p<0.001).
Fig 5
Fig 5. Blood glucose concentrations during OGTT (1.75 g/kg BW) in growing pigs displaying monophasic (n = 5; filled circles) and biphasic (n = 4; open circles) curves.
Fig 6
Fig 6. Blood glucose concentrations and plasma levels of insulin, glucagon and active GLP-1 during OGTT (2.5 g/kg BW) in one male 10 week old pig.

Similar articles

Cited by

References

    1. WHO. Diabetes Fact Sheet N312: World Health Organization; 2015 [2015-12-09]. Available: http://www.who.int/mediacentre/factsheets/fs312/en/.
    1. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. Jama. 2014;311(17):1778–86. 10.1001/jama.2014.3201 - DOI - PMC - PubMed
    1. Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010. JAMA. 2015;313(1):37–44. 10.1001/jama.2014.16425 - DOI - PMC - PubMed
    1. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167(11):1145–51. - PubMed
    1. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52. 10.1016/S0140-6736(13)60595-4 - DOI - PubMed

Publication types

MeSH terms